Datameds AI (MEDS) revenue and earnings history
Datameds AI reported revenue of $23.3M for fiscal 2025 (year ended Dec 31, 2025), +28.7% on the year before, and net income of −$101M.
Over 1 years, from fiscal 2024 to fiscal 2025, revenue grew at a compound rate of +28.7% a year.
Revenue and net income, 3 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $23.3M+28.7% | −$93.7M | −$101M | −$10.9M | — | — | $54.8M | — | — | $43K | $23.5M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Datameds AI (MEDS) on OQRO.
Common questions
What was Datameds AI's revenue in fiscal 2025?
$23.3M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 20, 2026. That is +28.7% on fiscal 2024 ($18.1M).
How fast has Datameds AI's revenue grown?
From $18.1M in fiscal 2024 to $23.3M in fiscal 2025: a compound annual growth rate of +28.7% over 1 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Datameds AI been profitable?
It reported a net loss in 3 of the years shown (2023, 2024, 2025). The highest net income was −$2.9M in fiscal 2023.
Why is earnings per share not in this table?
Where these figures come from
The SEC’s companyfacts data: every figure Datameds AI tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.